Video consultations in the care for patients with a chronic somatic disease
Authors: Mistiaen Patriek , Devriese Stephan , Pouppez Céline , Roberfroid Dominique , Savoye Isabelle 
Published: January 2025

SCIENTIFIC REPORT 10 -- 1 BACKGROUND AND AIM OF THE STUDY 10 -- 2 RAPID REVIEW OF REVIEWS ON VIDEO CONSULTATION FOR PATIENTS WITH A CHRONIC SOMATIC DISEASE .13 -- 2.1 KEY-FINDINGS 13 -- 2.2 METHODOLOGY 13 -- 2.2.1 Searches 14 -- 2.2.2 In/exclusion process and criteria 18 -- 2.2.3 Data-extraction and synthesis 22 -- 2.3 RESULTS 22 -- 2.3.1 Search results 22 -- 2.3.2 Effects of video consultation on patients 23 -- 2.3.3 Provider effects .38 -- 2.3.4 Barriers and facilitators in the implementation of video consultations 40 -- 2.3.5 Our findings compared to other reviews of reviews 44 -- 2.4 CONCLUSION AND DISCUSSION 53 -- 3 VIDEO CONSULTATIONS IN BELGIAN HEALTH CARE 55 -- 3.1 KEY FINDINGS 55 -- 3.2 METHODOLOGY 56 -- 3.3 TERMINOLOGY 56 -- 3.4 LEGISLATION 56 -- 3.4.1 Applicability .56 -- 3.4.2 Liability 59 -- 3.4.3 Privacy and security 60 -- 3.4.4 Certification .61 -- 3.5 FUNDING 61 -- 3.6 REMUNERATION 62 -- 3.7 REIMBURSEMENT 62 -- 3.7.1 Physicians 62 -- 3.7.2 Other healthcare professions .63 -- 3.8 TECHNOLOGY 64 -- 3.9 EFFECTS 65 -- 3.10 HISTORY/IMPLEMENTATION 65 -- 3.10.1 RIZIV-INAMI workshop on telemedicine 65 -- 3.10.2 SIMBA 66 -- 3.10.3 AXA Doctors Online 70 -- 3.10.4 Wit-Gele Kruis West-Vlaanderen .70 -- 3.10.5 lObservatoire de la Santé de la Province de Luxembourg .72 -- 4 VIDEO CONSULTATIONS IN FRENCH HEALTH CARE .73 -- 4.1 KEY POINTS .73 -- 4.2 METHODOLOGY 75 -- 4.3 HISTORY/IMPLEMENTATION 75 -- 4.3.1 History 75 -- 4.3.2 What barriers/facilitators were encountered during implementation? 75 -- 4.3.3 How were barriers in implementation solved? 76 -- 4.3.4 Which institutions are responsible for the deployment of teleconsultation in France? .77 -- 4.3.5 What is current scale of teleconsultation? 77 -- 4.4 LEGISLATION 79 -- 4.4.1 Applicability .80 -- 4.4.2 COVID-19 .81 -- 4.4.3 Liability 82 -- 4.4.4 Certification .82 -- 4.4.5 Privacy and ethics 82 -- 4.4.6 Ethical aspects 83 -- 4.5 FUNDING 83 -- 4.6 REMUNERATION 83 -- 4.7 REIMBURSEMENT 84 -- 4.7.1 Conditions 84 -- 4.7.2 Price 86 -- 4.8 TECHNOLOGY 87 -- 4.8.1 Exchange modalities 88 -- 4.8.2 Teleconsultation solutions 89 -- 4.8.3 Recommendations from the French National Authority for Health .89 -- 4.9 ACTORS 91 -- 4.10 POLICY 93 -- 4.11 EFFECTS 93 -- 5 VIDEO CONSULTATIONS IN DUTCH HEALTH CARE 93 -- 5.1 KEY FINDINGS 93 -- 5.2 METHODOLOGY 95 -- 5.3 CHARACTERISTICS OF THE DUTCH HEALTH SYSTEM .96 -- 5.4 TERMINOLOGY 97 -- 5.5 HISTORY / IMPLEMENTATION OF TELECONSULTATION/VIDEO CONSULTATION 98 -- 5.5.1 History 98 -- 5.5.2 What barriers were encountered during implementation of video consultation? 104 -- 5.5.3 How were barriers in implementation solved? 106 -- 5.6 LEGISLATION 106 -- 5.6.1 List of legislations 106 -- 5.6.2 Applicability 107 -- 5.6.3 Liability 112 -- 5.6.4 Certification 113 -- 5.6.5 Privacy and ethics .114 -- 5.7 FUNDING .114 -- 5.7.1 Budget of the private insurers .114 -- 5.7.2 Subsidies granted by the public authorities .114 -- 5.8 REMUNERATION 115 -- 5.9 REIMBURSEMENT .116 -- 5.10 TECHNOLOGY .116 -- 5.11 EFFECTS .117 -- 5.11.1 The eHealth Monitor .117 -- 5.11.2 The ZonMW study .117 -- 5.11.3 The NZa study on teleconsultation in the specialized care 117 -- 5.12 COVID-19 PANDEMIC 119 -- 5.12.1 Governmental measures 119 -- 5.12.2 Privates initiatives .120 -- 6 GENERAL DISCUSSION AND CONCLUSIONS 121 -- REFERENCES 123 -- APPENDICES 144